ALNYLAM PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2010 to Q2 2024.
  • Alnylam Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 128M shares, a 2.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 128M +3.12M +2.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 126M +2.22M +1.79% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 126M +1.87M +1.51% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 125M +2.46M +2% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 125M +3.91M +3.23% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 124M +3.51M +2.91% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 124M +3.74M +3.11% Dec 31, 2022 10-K 2024-02-15
Q3 2022 123M +3.51M +2.94% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 121M +2.4M +2.02% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 121M +3.41M +2.91% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 120M +3.76M +3.23% Dec 31, 2021 10-K 2023-02-23
Q3 2021 119M +3.34M +2.87% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 119M +2.95M +2.55% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 117M +4.15M +3.67% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 116M +4.24M +3.78% Dec 31, 2020 10-K 2022-02-10
Q3 2020 116M +4.82M +4.33% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 116M +4.53M +4.08% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 113M +6.77M +6.36% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 112M +11M +10.9% Dec 31, 2019 10-K 2021-02-11
Q3 2019 111M +10.4M +10.3% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 111M +10.5M +10.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 106M +5.93M +5.9% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 101M +1.51M +1.52% Dec 31, 2018 10-K 2020-02-13
Q3 2018 101M +8.6M +9.31% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 101M +8.87M +9.67% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 100M +14.4M +16.7% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 99.7M +13.7M +16% Dec 31, 2017 10-K 2019-02-14
Q3 2017 92.4M +6.6M +7.7% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 91.7M +6.13M +7.16% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 86.1M +605K +0.71% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 85.9M +850K +1% Dec 31, 2016 10-K 2018-02-15
Q3 2016 85.8M +1.06M +1.25% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 85.6M +1.04M +1.23% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 85.5M +1.25M +1.48% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 85.1M +7.89M +10.2% Dec 31, 2015 10-K 2017-02-15
Q3 2015 84.7M +8.03M +10.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 84.5M +8.21M +10.8% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 84.2M +8.73M +11.6% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 77.2M +13.5M +21.1% Dec 31, 2014 10-K 2016-02-12
Q3 2014 76.7M +13.4M +21.3% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 76.3M +13.9M +22.2% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 75.5M +13.4M +21.5% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 63.7M +11.3M +21.4% Dec 31, 2013 10-K 2015-02-13
Q3 2013 63.2M +10.9M +20.7% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 62.5M +10.5M +20.1% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 62.1M +10.2M +19.7% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 52.5M +9.77M +22.9% Dec 31, 2012 10-K 2014-02-20
Q3 2012 52.4M +9.69M +22.7% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 52M +9.34M +21.9% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 51.9M +9.53M +22.5% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 42.7M +379K +0.89% Dec 31, 2011 10-K 2013-02-19
Q3 2011 42.7M +528K +1.25% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 42.7M +557K +1.32% Jun 30, 2011 10-Q 2011-08-03
Q1 2011 42.4M Mar 31, 2011 10-Q 2011-05-05
Q4 2010 42.3M Dec 31, 2010 10-K 2012-02-13
Q3 2010 42.2M Sep 30, 2010 10-Q 2010-11-04
Q2 2010 42.1M Jun 30, 2010 10-Q 2010-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.